Louis Hui - Avivagen Director - Business Development
| VIV Stock | CAD 0.01 0.00 0.00% |
Director
Mr. Louis Hui serves as Director Business Development of the Company since 2017.
| Tenure | 7 years |
| Address | 100 Sussex Drive, Ottawa, ON, Canada, K1A 0R6 |
| Phone | 613-702-2908 |
| Web | https://www.avivagen.com |
Avivagen Management Efficiency
The company has return on total asset (ROA) of (1.9344) % which means that it has lost $1.9344 on every $100 spent on assets. This is way below average. Avivagen's management efficiency ratios could be used to measure how well Avivagen manages its routine affairs as well as how well it operates its assets and liabilities. Return On Capital Employed is likely to climb to 2.28 in 2024, whereas Return On Tangible Assets are likely to drop (4.20) in 2024. At this time, Avivagen's Total Assets are fairly stable compared to the past year. Non Current Assets Total is likely to climb to about 148.9 K in 2024, whereas Intangible Assets are likely to drop 347.99 in 2024.Similar Executives
| Showing other executives | DIRECTOR Age | ||
| Brad Bennett | Exchange Income | 61 | |
| Donald Streuber | Exchange Income | 61 | |
| William Maslechko | Rogers Sugar | 57 | |
| Gary Collins | Rogers Sugar | 55 | |
| Tony Hupman | Chemtrade Logistics Income | N/A | |
| Serena Kraayeveld | Exchange Income | 67 | |
| Gary Buckley | Exchange Income | 58 | |
| Dean Bergmame | Rogers Sugar | N/A | |
| Allan Davis | Exchange Income | 62 | |
| Jeffrey Olin | Exchange Income | 52 | |
| Melissa Sonberg | Exchange Income | 58 | |
| Edward Warkentin | Exchange Income | 69 | |
| Michel Desbiens | Rogers Sugar | 75 | |
| Dallas Ross | Rogers Sugar | N/A | |
| Stuart Belkin | Rogers Sugar | N/A | |
| Polly Craik | Exchange Income | 57 | |
Management Performance
| Return On Asset | -1.93 |
Avivagen Leadership Team
Elected by the shareholders, the Avivagen's board of directors comprises two types of representatives: Avivagen inside directors who are chosen from within the company, and outside directors, selected externally and held independent of Avivagen. The board's role is to monitor Avivagen's management team and ensure that shareholders' interests are well served. Avivagen's inside directors are responsible for reviewing and approving budgets prepared by upper management to implement core corporate initiatives and projects. On the other hand, Avivagen's outside directors are responsible for providing unbiased perspectives on the board's policies.
| Tracy BVSC, Director Manager | ||
| David Hankinson, Executive Director | ||
| Louis Hui, Director - Business Development | ||
| Chris Boland, CFO | ||
| David Allan, Director | ||
| Ira Levy, Interim Officer | ||
| Amin Khalifa, Independent Director | ||
| Aubrey Dan, Director | ||
| Cameron Groome, CEO and President and Director | ||
| Vanessa Grant, Director | ||
| Andrew Basek, Director of Investor Relations | ||
| Drew Basek, Director of Investor Relations | ||
| Paul Mesburis, Lead Director | ||
| James Nickerson, President Innovation | ||
| Graham Burton, Co-Founder, Director of Commercialization Science and Director | ||
| G Anthony, Independent Director |
Avivagen Stock Performance Indicators
The ability to make a profit is the ultimate goal of any investor. But to identify the right stock is not an easy task. Is Avivagen a good investment? Although profit is still the single most important financial element of any organization, multiple performance indicators can help investors identify the equity that they will appreciate over time.
| Return On Asset | -1.93 | ||||
| Operating Margin | (10.47) % | ||||
| Current Valuation | 7.61 M | ||||
| Shares Outstanding | 77.69 M | ||||
| Shares Owned By Insiders | 1.11 % | ||||
| Number Of Shares Shorted | 6.25 K | ||||
| Price To Earning | (7.32) X | ||||
| Price To Sales | 0.54 X | ||||
| Revenue | 939.17 K | ||||
| Gross Profit | 400.3 K |
Also Currently Popular
Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.Check out World Market Map to better understand how to build diversified portfolios, which includes a position in Avivagen. Also, note that the market value of any company could be tightly coupled with the direction of predictive economic indicators such as signals in board of governors. You can also try the Commodity Channel module to use Commodity Channel Index to analyze current equity momentum.
Complementary Tools for Avivagen Stock analysis
When running Avivagen's price analysis, check to measure Avivagen's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Avivagen is operating at the current time. Most of Avivagen's value examination focuses on studying past and present price action to predict the probability of Avivagen's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Avivagen's price. Additionally, you may evaluate how the addition of Avivagen to your portfolios can decrease your overall portfolio volatility.
| Investing Opportunities Build portfolios using our predefined set of ideas and optimize them against your investing preferences | |
| Equity Search Search for actively traded equities including funds and ETFs from over 30 global markets | |
| Financial Widgets Easily integrated Macroaxis content with over 30 different plug-and-play financial widgets | |
| Aroon Oscillator Analyze current equity momentum using Aroon Oscillator and other momentum ratios | |
| My Watchlist Analysis Analyze my current watchlist and to refresh optimization strategy. Macroaxis watchlist is based on self-learning algorithm to remember stocks you like |